JPWO2021034418A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021034418A5
JPWO2021034418A5 JP2021578241A JP2021578241A JPWO2021034418A5 JP WO2021034418 A5 JPWO2021034418 A5 JP WO2021034418A5 JP 2021578241 A JP2021578241 A JP 2021578241A JP 2021578241 A JP2021578241 A JP 2021578241A JP WO2021034418 A5 JPWO2021034418 A5 JP WO2021034418A5
Authority
JP
Japan
Prior art keywords
virus
peptide
pharmaceutical composition
cell
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021578241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538903A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040720 external-priority patent/WO2021034418A2/en
Publication of JP2022538903A publication Critical patent/JP2022538903A/ja
Publication of JPWO2021034418A5 publication Critical patent/JPWO2021034418A5/ja
Pending legal-status Critical Current

Links

JP2021578241A 2019-07-02 2020-07-02 細胞および組織への薬剤の送達のための新規ペプチド、組成物および方法 Pending JP2022538903A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962869831P 2019-07-02 2019-07-02
US62/869,831 2019-07-02
PCT/US2020/040720 WO2021034418A2 (en) 2019-07-02 2020-07-02 Novel peptide, compositions and method for delivery of agents into cells and tissues

Publications (2)

Publication Number Publication Date
JP2022538903A JP2022538903A (ja) 2022-09-06
JPWO2021034418A5 true JPWO2021034418A5 (pt) 2023-07-11

Family

ID=74659924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021578241A Pending JP2022538903A (ja) 2019-07-02 2020-07-02 細胞および組織への薬剤の送達のための新規ペプチド、組成物および方法

Country Status (9)

Country Link
US (2) US11713337B2 (pt)
EP (1) EP3994151A4 (pt)
JP (1) JP2022538903A (pt)
KR (1) KR20220039725A (pt)
CN (1) CN114555625A (pt)
AU (1) AU2020332268A1 (pt)
CA (1) CA3144963A1 (pt)
IL (1) IL289516A (pt)
WO (1) WO2021034418A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210018323A (ko) 2018-06-06 2021-02-17 매사추세츠 인스티튜트 오브 테크놀로지 진핵 세포에서의 번역을 위한 원형 rna

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211657A (en) * 1988-11-07 1993-05-18 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
DE19827457C1 (de) * 1998-06-19 2000-03-02 Medigene Ag Strukturprotein von AAV, seine Herstellung und Verwendung
US7396664B2 (en) 1999-06-08 2008-07-08 Regeneron Pharmaceuticals, Inc. VEGF-binding fusion proteins and nucleic acids encoding the same
JP3635462B2 (ja) * 2000-05-31 2005-04-06 国立医薬品食品衛生研究所長 アデノウイルスベクター
SE0301431D0 (sv) * 2003-05-19 2003-05-19 Dermagen Novel antimicrobial peptides
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
JP2010537632A (ja) * 2007-08-29 2010-12-09 タフツ ユニバーシティー 組織及び細胞への核酸、タンパク質、薬物、及びアデノウイルスの送達を向上させるための細胞透過性ペプチドの製造及び使用方法、組成物並びにキット
JP5384501B2 (ja) * 2007-09-11 2014-01-08 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのペプチドｐｈｐｆｈｌｆｖｙ（レニンインヒビター）の使用
BRPI1015424B1 (pt) * 2009-06-22 2022-01-18 Burnham Institute For Medical Research Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição
US20130158103A1 (en) * 2011-11-23 2013-06-20 The Curators Of The University Of Missouri Method of Tissue-Selective Targeted Gene Transfer
EP4289274A3 (en) * 2013-12-04 2024-03-06 Newleaf Symbiotics, Inc. Compositions for treating plants
US10316061B2 (en) * 2014-10-02 2019-06-11 Temple University Of The Commonwealth System Of Higher Education Synthesis of cell penetrating peptides for drug delivery and stem cell applications
CN108064229B (zh) * 2015-03-12 2021-12-28 三洋化成工业株式会社 蛋白质组合物的制造方法和蛋白质组合物
KR20170135957A (ko) * 2015-04-10 2017-12-08 펠단 바이오 인코포레이티드 표적 진핵세포의 세포질로의 폴리펩타이드 카고의 형질 도입 효과를 향상시키기 위한 폴리펩타이드계 셔틀제, 이의 용도, 방법 및 이에 관련된 키트

Similar Documents

Publication Publication Date Title
JP7503590B2 (ja) 遺伝子構築物
Peng et al. Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
JP2021503914A5 (pt)
RU2018142768A (ru) Варианты капсидов аденоассоциированного вируса и способы их применения
US20090011040A1 (en) Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
WO2011079175A1 (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
US20240050527A1 (en) METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF
US20230340024A1 (en) Novel peptide, compositions and method for delivery of agents into cells and tissues
CN111705069A (zh) 一种多神经营养因子联合表达载体及其应用
JPWO2021034418A5 (pt)
JP2023531289A (ja) 眼病態の処置のためのｄｎａ構造
US20210308169A1 (en) Methods and compositions for treatment of retinal degenerative diseases
EP3893918B1 (en) Vasodilators for use in the treatment of a retinal ischemic disorder
Chan Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting. Baltimore, Maryland, USA-May 7-11, 2017
US20050106729A1 (en) Gene transfer methods and compositions
RU2023130643A (ru) Композиции и способы для лечения заболевания глаз, ассоциированного с ангиогенезом
RU2020121215A (ru) Варианты капсидов аденоассоциированного вируса и их применение для ингибирования ангиогенеза
JPWO2021041373A5 (pt)
Rafieetary et al. Gene therapy delivery: Examining the evidence
JP2006516112A5 (pt)